Signant's Solutions Support Coronavirus Research & Vaccine Development Date Published: May 27, 2021 Video Signant improves endpoint data quality and expedites study processes for vaccine clinical trials, including the recent coronavirus. Our SmartSignals solutions and team of experts help with: Large patient populations Trial data management Collect primary data Every trial – from traditional to hybrids and fully remote – can benefit from new technologies. Whether you start by implementing one digital solution or opt for the full SmartSignals suite, we train and advise study teams, so you can reach your research goals. Share: LinkedInTweet Recommended Resources Video Pain Clinical Research Solutions Signant’s SmartSignals solutions improve processes and overall efficiencies in pain clinical research. Each solution was designed by our in-house experts... Watch Now Video About Virtual Site Monitoring Viewers will see how the proprietary eyewear technology can be used for remote site monitoring. In this video, a study... Watch Now Article #NoGoingBack: Make the Pledge In this Pharmaceutical Outsourcing feature, Signant Health's Chief Marketing Officer Scott Connor argues why the industry can’t afford to lose the progress made during COVID-19. He details why the #NoGoingBack industry-wide social movement matters. Chaired by industry members across organizations, #NoGoingBack has shown that competitors can and should collaborate to help protect research and allow it to reach new levels. Read more on how the adoption of technology benefits the greater research, not just COVID-19 vaccines. Interested in joining the movement? Pledge your name by visiting: www.nogoingback.health. Download Now